A rapid screen for lupus anticoagulant with good discrimination from oral anticoagulants, congenital factor deficiency and heparin, is provided by comparing a sensitive and an insensitive APTT reagent

Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
V BrancaccioI Mackie

Abstract

Lupus anticoagulants (LA) are associated with an increased risk of thrombosis and laboratory detection is of major importance. Various tests are available for LA screening and confirmation, but they differ in sensitivity and specificity, frequently lacking the ability to discriminate between the presence of LA, heparin and oral anticoagulants. We noticed that a patient with LA who had a prolonged activated partial thromboplastin time (APTT) by our routine method, gave a normal result with a different APTT reagent. This latter reagent, which contained soy bean phosphatides (SBP), was compared with a reagent containing rabbit brain phospholipids complexed with kaolin (RBK), for APTT measurement in a variety of patients. There was no significant difference in APTT ratio between the two reagents in plasma samples from healthy normal subjects. In LA samples, SBP gave consistently lower APTT ratios than RBK (mean +/- SEM, 1.04 +/- 0.05 and 2.08 +/- 0.19 for SBP and RBK respectively; P < 0.001). In LA patients receiving oral anticoagulants for antithrombotic prophylaxis or treatment, the APTT ratio was again significantly shorter with SBP (1.60 +/- 0.17 and 3.40 +/- 0.67; P < 0.05). In LA negative patients receiving oral anticoagulant...Continue Reading

Citations

Apr 5, 2003·Thrombosis Research·Finn WisløffSigurd Liestøl
Aug 6, 2000·British Journal of Haematology·M GreavesI Mackie
Oct 31, 2002·British Journal of Haematology·Ian JenningsUNKNOWN UK National External Quality Assessment Scheme for Blood Coagulation
May 7, 2008·Current Rheumatology Reports·Richard A Marlar, Sanam Husain
Feb 13, 2016·Thrombosis and Haemostasis·Paul R J AmesVincenzo Brancaccio
Jan 19, 2011·Blood Reviews·Rolf T Urbanus, Philip G de Groot
Jul 3, 2007·Thrombosis Research·G W MooreS Rangarajan
Apr 25, 2006·Clinical and Laboratory Haematology·M R AboudL Coyle
Feb 4, 2009·Journal of Thrombosis and Haemostasis : JTH·P R J AmesA Margarita
Sep 24, 2010·International Journal of Laboratory Hematology·R LuginbühlL Alberio
Sep 18, 2012·International Journal of Laboratory Hematology·I MackieUNKNOWN British Committee for Standards in Haematology
Oct 28, 2004·Thrombosis Research·Ronald H W M Derksen, Philip G de Groot
Jul 18, 2002·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Edelgard Lindhoff-LastRupert Bauersachs
Jun 22, 2007·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Vânia Maris MorelliDayse Maria Lourenço
Jul 10, 2003·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Shrimati ShettyDipika Mohanty
Feb 13, 2020·European Journal of Haematology·Katrine Laura RasmussenJens Peter Goetze
Oct 31, 2001·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·P R AmesV Brancaccio
Dec 6, 2001·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·P R AmesV Brancaccio

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.